Your browser doesn't support javascript.
loading
Effectiveness and acceptability of metformin in preventing the onset of type 2 diabetes after gestational diabetes in postnatal women: a protocol for a randomised, placebo-controlled, double-blind feasibility trial­Optimising health outcomes with Metformin to prevent diAbetes After pregnancy (OMAhA).
Amaefule, Chiamaka Esther; Bolou, Angeliki; Drymoussi, Zoe; Gonzalez Carreras, Francisco Jose; Pardo Llorente, Maria Del Carmen; Lanz, Doris; Dodds, Julie; Sweeney, Lorna; Pizzo, Elena; D'Amico, Maria; Thomas, Amy; Heighway, James; Daru, Jahnavi; Sobhy, Soha; Robson, John; Sanghi, Anita; Zamora, Javier; Harden, Angela; Hitman, Graham; Khan, Khalid; Pérez, Teresa; Huda, Mohammed Sb; Thangaratinam, Shakila.
Afiliação
  • Amaefule CE; Barts Research Centre for Women's Health (BARC), Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK c.e.amaefule@qmul.ac.uk.
  • Bolou A; Barts Research Centre for Women's Health (BARC), Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Drymoussi Z; Department of Family Care and Mental Health, University of Greenwich, London, UK.
  • Gonzalez Carreras FJ; Barts Research Centre for Women's Health (BARC), Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Pardo Llorente MDC; Barts Research Centre for Women's Health (BARC), Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Lanz D; Barts Research Centre for Women's Health (BARC), Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Dodds J; Department of Statistics and Operational Research, Complutense University of Madrid, Madrid, Spain.
  • Sweeney L; Barts Research Centre for Women's Health (BARC), Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Pizzo E; Barts Research Centre for Women's Health (BARC), Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • D'Amico M; Institute for Health and Human Development, University of East London, London, UK.
  • Thomas A; Collaborations for Leadership in Applied Health Research and Care (CLAHRC) for North Thames London, Department of Applied Health Research, University College London, London, UK.
  • Heighway J; Barts Research Centre for Women's Health (BARC), Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Daru J; Barts Research Centre for Women's Health (BARC), Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Sobhy S; Women's and Children's Health, Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Robson J; Barts Research Centre for Women's Health (BARC), Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Sanghi A; Barts Research Centre for Women's Health (BARC), Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Zamora J; Barts Research Centre for Women's Health (BARC), Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Harden A; Women's and Children's Health, Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Hitman G; Clinical Effectiveness Group, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Khan K; Women's Division, Royal London Hospital, Barts Health NHS Trust, London, UK.
  • Pérez T; Clinical Biostatistics Unit (IRYCIS) and CIBER Epidemiology and Public Health, Ramon y Cajal University Hospital, Madrid, Spain.
  • Huda MS; Institute for Health and Human Development, University of East London, London, UK.
  • Thangaratinam S; Barts Research Centre for Women's Health (BARC), Institute of Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
BMJ Open ; 10(5): e036198, 2020 05 17.
Article em En | MEDLINE | ID: mdl-32423937
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Diabetes Gestacional / Diabetes Mellitus Tipo 2 / Metformina Limite: Female / Humans / Pregnancy País/Região como assunto: Europa Idioma: En Revista: BMJ Open Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Diabetes Gestacional / Diabetes Mellitus Tipo 2 / Metformina Limite: Female / Humans / Pregnancy País/Região como assunto: Europa Idioma: En Revista: BMJ Open Ano de publicação: 2020 Tipo de documento: Article